OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
2
Results
Show all
Save search
Copy query
Show results for
Unknown
(2)
Omics type
Unknown
(2)
Release Date
2021
(1)
2020
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
0
0
0 Views
0
0 Connections
0
0 Citations
0
0 Reanalyses
0
0 Downloads
Omics score:
0
The Second of Two One-Year, Mu
l
ticenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Not available
S-EPMC8598184
|
biostudies-literature
Cite
0
0
0 Views
0
0 Connections
0
0 Citations
0
0 Reanalyses
0
0 Downloads
Omics score:
0
Daxibotu
l
inumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2).
Not available
S-EPMC6940025
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
